Our data highlight the critical role of the NF-κB/miR-335-3p/APJ axis in CNH-induced PAH; consequently, miR-335-3p may be a potential therapeutic target against PAH during hypoxia. This evidence concerns the gene NFKB1 and pulmonary arterial hypertension.